These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 1108853)

  • 21. [Coexistence of pure red cell aplasia and autoimmune hemolytic anemia occurring during remission of malignant lymphoma].
    Toyota S; Nakamura N; Dan K
    Rinsho Ketsueki; 2002 Jun; 43(6):493-5. PubMed ID: 12134708
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Primary diffuse large B-cell lymphoma of the bone marrow complicated with autoimmune hemolytic anemia and erythroid hypoplasia].
    Sumi M; Ichikawa N; Shimizu I; Yotsumoto M; Ueno M; Kobayashi H
    Rinsho Ketsueki; 2007 Jul; 48(7):571-5. PubMed ID: 17695307
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cyclosporine therapy of aplastic anaemia, congenital and acquired red cell aplasia.
    Leonard EM; Raefsky E; Griffith P; Kimball J; Nienhuis AW; Young NS
    Br J Haematol; 1989 Jun; 72(2):278-84. PubMed ID: 2503027
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of histiocytic lymphoma in Uganda adults.
    Olweny CL; Ziegler JL
    East Afr Med J; 1971 Oct; 48(10):585-91. PubMed ID: 4946665
    [No Abstract]   [Full Text] [Related]  

  • 25. [De novo CD5-positive diffuse large B-cell lymphoma associated with autoimmune hemolytic anemia presenting as erythroid hypoplasia].
    Kuroda H; Matsunaga T; Iyama S; Takimoto R; Shirao S; Kida M; Watanabe H; Konuma Y; Hirayama Y; Kohda K; Niitsu Y
    Rinsho Ketsueki; 2006 Jul; 47(7):633-8. PubMed ID: 16910573
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combination chemotherapy of advanced diffuse histiocytic lymphoma with the six-drug COP-BLAM regimen.
    Laurence J; Coleman M; Allen SL; Silver RT; Pasmantier M
    Ann Intern Med; 1982 Aug; 97(2):190-5. PubMed ID: 6179448
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Advanced diffuse histiocytic lymphoma, a potentially curable disease.
    DeVita VT; Canellos GP; Chabner B; Schein P; Hubbard SP; Young RC
    Lancet; 1975 Feb; 1(7901):248-50. PubMed ID: 46388
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Localized Castleman's disease associated with high-grade lymphoma].
    Sanz García RM; Guerra Vales JM; de Prada I; Martínez MA; Guillén Camargo V
    An Med Interna; 1999 Jun; 16(6):305-7. PubMed ID: 10422302
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Maintenance therapy with interferon-alpha 2b, cyclophosphamide, and prednisone in aggressive diffuse large cell lymphoma.
    Avilés A; Neri N; Nambo MJ; Castañeda C; Talavera A; Huerta-Guzmán J; Murillo E
    Stem Cells Dev; 2004 Apr; 13(2):205-9. PubMed ID: 15186737
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pure red blood cell aplasia and chronic lymphocytic leukemia.
    Abeloff MD; Waterbury L
    Arch Intern Med; 1974 Oct; 134(4):721-4. PubMed ID: 4415396
    [No Abstract]   [Full Text] [Related]  

  • 31. Acquired pure red cell aplasia: case report of a patient responding to prednisone.
    Magesa PM; Arunkumar BK; Lema RA; Kwai PA; Mwanukuzi PN
    East Afr Med J; 1982 Jul; 59(7):492-5. PubMed ID: 7160328
    [No Abstract]   [Full Text] [Related]  

  • 32. [Cyclophosphamide-vincristine-prednisone combination in the treatment of lympho- and reticulosarcomas in adults (60 cases)].
    Gorin NC; David R; Stachowiak J; Najman A; Duhamel G
    Nouv Presse Med; 1976 Nov; 5(38):2525-30. PubMed ID: 790316
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic factors for advanced diffuse histiocytic lymphoma following treatment with combination chemotherapy.
    Fisher RI; DeVita VT; Johnson BL; Simon R; Young RC
    Am J Med; 1977 Aug; 63(2):177-82. PubMed ID: 70170
    [TBL] [Abstract][Full Text] [Related]  

  • 34. BCNU with and without cyclophosphamide, vincristine, and prednisone (COP) and cycle-active therapy in non-Hodgkin's lymphoma.
    Durant JR; Gams RA; Bartolucci AA; Dorfman RF
    Cancer Treat Rep; 1977 Sep; 61(6):1085-96. PubMed ID: 332345
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Pure red cell aplasia associated with thymoma. Demonstration of an autoimmune serum factor inhibiting erythropoiesis and remission induced by cyclophosphamide].
    Peschle C; Condorelli M
    Haematologica; 1972; 58(9):553-9. PubMed ID: 4206229
    [No Abstract]   [Full Text] [Related]  

  • 36. Diagnosis and treatment of pure red cell aplasia.
    Krantz SB
    Med Clin North Am; 1976 Sep; 60(5):945-58. PubMed ID: 781416
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epstein-Barr virus associated diffuse large B-cell lymphoma complicated by autoimmune hemolytic anemia and pure red cell aplasia.
    Katayama H; Takeuchi M; Yoshino T; Munemasa M; Tada A; Soda R; Takahashi K
    Leuk Lymphoma; 2001 Jul; 42(3):539-42. PubMed ID: 11699422
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combined cyclophosphamide vincristine, procarbazine, and prednisone (COPP) therapy of malignant lymphoma. Evaluation of 190 patients.
    Morgenfeld MC; Pavlovsky A; Suarez A; Somoza N; Pavlovsky S; Palau M; Barros CA
    Cancer; 1975 Oct; 36(4):1241-9. PubMed ID: 1100220
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunosuppressive treatment of pure red-cell aplasia.
    Vilan J; Rhyner K; Ganzoni A
    Lancet; 1971 Jul; 2(7714):51. PubMed ID: 4103702
    [No Abstract]   [Full Text] [Related]  

  • 40. Successful immunosuppressive treatment of erythroid aplasia appearing after thymectomy.
    Safdar SH; Krantz SB; Brown EB
    Br J Haematol; 1970 Oct; 19(4):435-43. PubMed ID: 5312272
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.